[go: up one dir, main page]

De La Maza et al., 1975 - Google Patents

Integration of avian sarcoma virus specific DNA in mammalian chromatin

De La Maza et al., 1975

View PDF
Document ID
699953491544095494
Author
De La Maza L
Faras A
Varmus H
Vogt P
Yunis J
Publication year
Publication venue
Experimental cell research

External Links

Snippet

Constitutive heterochromatin and euchromatin fractions from normal and avian sarcoma virus transformed cells of Mus musculur and Microtus agrestis were isolated in order to characterize the site of integration of the viral specific DNA sequences. The transformed …
Continue reading at deepblue.lib.umich.edu (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses, e.g. hepatitis E virus

Similar Documents

Publication Publication Date Title
Ferreras et al. SARS-CoV-2-specific memory T lymphocytes from COVID-19 convalescent donors: identification, biobanking, and large-scale production for adoptive cell therapy
Montagnier et al. Adaptation of lymphadenopathy associated virus (LAV) to replication in EBV-transformed B lymphoblastoid cell lines
Wu et al. Induction of antibody‐secreting cells and T‐helper and memory cells in murine nasal lymphoid tissue
Fazle Akbar et al. Upregulation of MHC class II antigen on dendritic cells from hepatitis B virus transgenic mice by interferon‐γ: abrogation of immune response defect to a T‐cell‐dependent antigen
Sotelo et al. Varicella‐zoster virus in cerebrospinal fluid at relapses of multiple sclerosis
Lamon et al. IgM antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: the involvement of T and B lymphocytes as effector cells
Blank et al. Evidence for an H–2/viral protein complex on the cell surface as the basis for the H–2 restriction of cytotoxicity
Edenberg Novobiocin inhibition of simian virus 40 DNA replication
Blanton et al. Immunoprecipitation of virus-specific immediate-early and early polypeptides from cells lytically infected with human cytomegalovirus strain AD 169
Aaronson et al. Transformation and virus growth by murine sarcoma viruses in human cells
Leddy et al. Effect of selective complement deficiency on the rate of neutralization of enveloped viruses by human sera
Zeijlemaker et al. Cytotoxic activity of human lymphocytes: quantitative analysis of T cell and K cell cytotoxicity, revealing enzyme-like kinetics
Kurnit et al. Subnuclear redistribution of DNA species in confluent and growing mammalian cells
Okabe et al. Immunological and biochemical characterisation of type C viruses isolated from cultured human AML cells
CN105820255A (en) Anti-CD33 chimeric antigen receptor, coding gene, recombinant expression vector and construction method and application of recombinant expression vector
CN105949316A (en) Anti-EGFRvIII chimeric antigen receptor, encoding gene, recombinant expression vector, construction method of recombinant expression vector, and application
Rozee et al. Effect of priming on interferon inhibition of Con A induced spleen cell blastogenesis
De La Maza et al. Integration of avian sarcoma virus specific DNA in mammalian chromatin
Ahmed et al. STUDIES ON NON‐H‐2 LINKED LYMPHOCYTE ACTIVATING DETERMINANTS I. DESCRIPTION OF THE CELL TYPE BEARING THE MLS PRODUCT
Bodemer et al. Detection of virus-specific antigens in EB-(P3HR1) virus-superinfected Raji cells by immunoprecipitation
Burakoff et al. Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens
Larsson et al. A cellular analysis of immunosuppression in cattle with mucosal disease
Xu et al. Diagnosis of cytomegalovirus infections using polymerase chain reaction, virus isolation and serology
Luft et al. A serum-free culture medium for channel catfish in vitro immune responses
Jachertz et al. Information carried by the DNA released by antigen-stimulated lymphocytes